Comparative Pharmacology
Head-to-head clinical analysis: CHLORAPREP SINGLE SWABSTICK versus HIBISTAT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CHLORAPREP SINGLE SWABSTICK versus HIBISTAT.
CHLORAPREP SINGLE SWABSTICK vs HIBISTAT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Chlorhexidine gluconate, a bisbiguanide antiseptic, disrupts microbial cell membranes and precipitates cytoplasmic contents at bactericidal concentrations.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), leading to cell lysis and death. Active against susceptible gram-positive bacteria.
Apply topically to intact skin as a single use swabstick. Allow to dry for 3 minutes. No frequency specified for single application.
1.5 mg/kg intravenously every 6 hours; maximum 120 mg per dose.
None Documented
None Documented
Chlorhexidine: terminal half-life approximately 3-5 hours after cutaneous application; prolonged with repeated use due to dermal reservoir effect. p-Chloroaniline: terminal half-life 10-12 hours.
Terminal elimination half-life is 2.5–3.5 hours in patients with normal renal function; prolonged in renal impairment, requiring dose adjustment.
Renal (minimal, <1% as unchanged drug); fecal/biliary (not significant); primarily metabolized to p-chloroaniline and subsequently excreted as conjugates in urine.
Approximately 90% of absorbed dose excreted renally as unchanged drug; <5% in feces via biliary elimination.
Category C
Category C
Antiseptic
Antiseptic